Table 1 Distribution of endocrine stimulation test according to suspected diagnosis and pathological tests in 2019 and 2020 (^a ITT were performed to detect both GHD and CAI simultaneously)

Suspected diagnosis

Stimulation test

N of performed tests

N of pathological tests

% of pathological tests

N of performed tests

N of pathological tests

% of pathological tests

GHD

ATT

95

39

41%

60

25

42%

ATT + GHRHT

1

1

100%

CTT

1

1

100%

ITT^a

31

25

81%

19

16

84%

NC-CAH

SDST

52

0

0%

56

1

2%

CPP

LHRHT

48

24

50%

54

28

52%

CAI

ITT^a

31

5

16%

19

4

21%

LDST

16

1

6%

13

1

8%

CRHT

1

0

0%

HH

LHRHT

18

5

28%

27

1

4%

AGHD

ATT + GHRHT

17

0

0%

15

1

7%

CH

TRHT

1

1

100%

OG

OGTT

4

2

50%